Hisense Precision Medical Products Debut at the National Twelfth Five-Year Science and Technology Innovation Achievement Exhibition
On June 1st, the “National Twelfth Five-Year Science and Technology Innovation Achievement Exhibition†was held in Beijing. The Hisense Computer Assisted Surgery System (Hisense CAS) and Hisense Surgical Intelligent Display System (Hisense) jointly developed by Hisense Group and Qingdao University Affiliated Hospital SID)" officially unveiled at the show. With the long-term accumulation of Hisense's display field and insight into precision medicine , Hisense is ready to take on the major strategic opportunities in the precision medical industry.
It is reported that Hisense Computer Assisted Surgery System and Hisense Surgical Intelligent Display System are jointly developed by Hisense expert team and Qingda Affiliated Research Team. They can transform the CT data of liver patients into three-dimensional digital liver to guide clinical operation. A comprehensive perspective to assess, plan, and design surgical procedures. At present, this system has been used clinically in more than 30 top three hospitals in China, such as Tsinghua Chang Gung Hospital, Fudan University Affiliated Pediatric Hospital, and Qingdao University Affiliated Hospital. More than 1,000 cases have been completed, and some foreign hospitals are actively introducing them. This system solves the painful point of surgical clinical operation, realizes digital precision medicine, rewrites the thinking mode and method of surgeon surgery, breaks the dilemma of China's high-tech digital medical equipment completely dependent on imports, benefits the global patients, and leads China. Digital medical has entered the world's leading ranks.
It is understood that in the "13th Five-Year Plan for National Economic and Social Development of the People's Republic of China", precision medicine is included in the strategic emerging industry development plan. According to industry analysis, with the “Healthy China†strategy, the medical and health industry around the “Healthy, Big Health and Great Medicine†during the “Thirteenth Five-Year Plan†is expected to exceed the market scale of 10 trillion. Hisense Medical has accumulated a new chapter in science and innovation in this emerging industry.
24% Flavonoids Ginkgo Biloba Extract is a kind of Ginkgo Biloba Leaf Extract, which is the Key Product of our company. The stems and leaves of Ginkgo Biloba Leaf are used as raw materials to extract, concentrate and dry yellow brown powder.
Ginkgo Biloba
Born in the sun, moist and fertile loam and sandy loam for china's specialty, generally for artificial cultivation.the cultivated area extends to liaoning in the north, guangdong in the south, zhejiang in the east, shaanxi and gansu in the west, and sichuan, guizhou and yunnan in the southwest.
It can improve brain circulation and protect brain cells and blood brain barrier.It can improve learning and memory, protect nerve, reduce hearing nerve damage, and significantly improve aging, dementia and brain dysfunction.For cardiovascular system, it can reduce myocardial oxygen consumption, protect ischemic myocardium, reduce the occurrence of arrhythmia, dilate blood vessels, and inhibit angiotensin-converting enzyme (ACE).Free radical scavenging, anti-lipid peroxidation;Antiplatelet activating factor, inhibiting platelet;It can enhance the stability of biofilm.It can relax tracheal smooth muscle directly and relieve spasm on gastrointestinal smooth muscle.It has the effect of lowering blood lipid;It has anti-microbial effect;Can increase the secretion of sebaceous glands, make dry or aging skin to increase ruddy color.Through the test, it has the effect of expanding the arteries and vessels, and can resist the vasoconstriction caused by adrenaline, and has the effect of lowering blood cholesterol in addition.
improving human immunity,Ginkgo Biloba Extract,Ginkgo Biloba Extract Powder,Quality Ginkgo Biloba Extract,Ginkgo Biloba Extract Plant
Shaanxi Kepler Biotech Co.,Ltd , https://www.keplerherb.com